Self-Assembled Affibody-PROTAC Nanomedicine Targets Cancer Cells
A new nanomedicine that combines a cancer-seeking protein with a molecular “degrader” has shown targeted activity against HER2-positive tumors in ...
A new nanomedicine that combines a cancer-seeking protein with a molecular “degrader” has shown targeted activity against HER2-positive tumors in ...
Cancer researchers have built a nanoscale drug-delivery system that attacks two problems inside certain tumors at once: malignant cells and ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine